McKesson Corporation (0JZU.L)
USD 656.76
(-7.55%)
USD 656.76
(-7.55%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.45 Billion USD | 22.41% |
| 2022 | 4.45 Billion USD | -9.03% |
| 2021 | 4.89 Billion USD | -21.05% |
| 2020 | 6.2 Billion USD | 0.26% |
| 2019 | 6.18 Billion USD | -14.88% |
| 2018 | 7.26 Billion USD | 7.61% |
| 2017 | 6.75 Billion USD | -7.58% |
| 2016 | 7.3 Billion USD | 12.44% |
| 2015 | 6.49 Billion USD | -20.57% |
| 2014 | 8.18 Billion USD | -8.39% |
| 2013 | 8.92 Billion USD | 97.5% |
| 2012 | 4.52 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 5.38 Billion USD | -0.52% |
| 2023 Q1 | 5.61 Billion USD | 26.0% |
| 2023 Q4 | 5.41 Billion USD | -3.72% |
| 2023 Q3 | 5.62 Billion USD | 1.63% |
| 2023 Q2 | 5.53 Billion USD | -1.35% |
| 2023 FY | 5.41 Billion USD | 21.63% |
| 2022 FY | 4.45 Billion USD | -9.03% |
| 2022 Q3 | 5.45 Billion USD | 13.28% |
| 2022 Q2 | 4.81 Billion USD | -3.06% |
| 2022 Q1 | 4.96 Billion USD | 1.43% |
| 2022 Q4 | 4.45 Billion USD | -18.32% |
| 2021 Q2 | 5.94 Billion USD | -7.44% |
| 2021 Q1 | 6.42 Billion USD | 3.61% |
| 2021 FY | 4.89 Billion USD | -21.05% |
| 2021 Q3 | 5.51 Billion USD | -7.2% |
| 2021 Q4 | 4.89 Billion USD | -11.29% |
| 2020 Q2 | 7.55 Billion USD | -5.85% |
| 2020 Q3 | 8.31 Billion USD | 10.04% |
| 2020 Q4 | 6.2 Billion USD | -25.46% |
| 2020 FY | 6.2 Billion USD | 0.26% |
| 2020 Q1 | 8.02 Billion USD | 0.43% |
| 2019 FY | 6.18 Billion USD | -14.88% |
| 2019 Q3 | 8.55 Billion USD | -6.11% |
| 2019 Q4 | 7.99 Billion USD | -6.52% |
| 2019 Q1 | 9.24 Billion USD | 26.72% |
| 2019 Q2 | 9.11 Billion USD | -1.49% |
| 2018 Q3 | 7.66 Billion USD | 14.69% |
| 2018 FY | 7.26 Billion USD | 7.61% |
| 2018 Q1 | 6.7 Billion USD | -3.81% |
| 2018 Q2 | 6.68 Billion USD | -0.36% |
| 2018 Q4 | 7.29 Billion USD | -4.79% |
| 2017 Q3 | 7.67 Billion USD | 0.72% |
| 2017 Q4 | 6.97 Billion USD | -9.17% |
| 2017 FY | 6.75 Billion USD | -7.58% |
| 2017 Q1 | 7.45 Billion USD | 1.98% |
| 2017 Q2 | 7.62 Billion USD | 2.31% |
| 2016 Q1 | 5.94 Billion USD | -8.65% |
| 2016 Q4 | 7.3 Billion USD | 22.38% |
| 2016 Q3 | 5.96 Billion USD | 0.47% |
| 2016 FY | 7.3 Billion USD | 12.44% |
| 2016 Q2 | 5.94 Billion USD | -0.02% |
| 2015 FY | 6.49 Billion USD | -20.57% |
| 2015 Q4 | 6.5 Billion USD | -15.68% |
| 2015 Q3 | 7.71 Billion USD | -5.17% |
| 2015 Q2 | 8.13 Billion USD | -0.07% |
| 2015 Q1 | 8.14 Billion USD | -0.46% |
| 2014 Q1 | 10.14 Billion USD | 13.57% |
| 2014 Q4 | 8.18 Billion USD | -8.92% |
| 2014 Q3 | 8.98 Billion USD | -6.64% |
| 2014 Q2 | 9.62 Billion USD | -5.14% |
| 2014 FY | 8.18 Billion USD | -8.39% |
| 2013 Q1 | 4.52 Billion USD | 0.02% |
| 2013 Q2 | 4.52 Billion USD | -0.02% |
| 2013 Q3 | 4.52 Billion USD | 0.0% |
| 2013 Q4 | 8.92 Billion USD | 97.5% |
| 2013 FY | 8.92 Billion USD | 97.5% |
| 2012 Q4 | 4.52 Billion USD | 13.79% |
| 2012 Q3 | 3.97 Billion USD | 0.0% |
| 2012 FY | 4.52 Billion USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -265932.211% |
| Accuray Incorporated | 164.4 Million USD | -3215.693% |
| Align Technology, Inc. | 96.96 Million USD | -5521.442% |
| Elevance Health Inc. | 23.24 Billion USD | 76.551% |
| AxoGen, Inc. | 46.6 Million USD | -11596.672% |
| Boston Scientific Corporation | 8.56 Billion USD | 36.365% |
| CVS Health Corporation | 74.67 Billion USD | 92.7% |
| Cardinal Health, Inc. | 4.58 Billion USD | -18.94% |
| Centene Corporation | 17.69 Billion USD | 69.202% |
| DaVita Inc. | 8.05 Billion USD | 32.296% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 85.118% |
| Hologic, Inc. | 2.49 Billion USD | -118.293% |
| Humana Inc. | 10.21 Billion USD | 46.627% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -775.124% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -34.437% |
| Masimo Corporation | 871.7 Million USD | -525.33% |
| Patterson Companies, Inc. | 328.91 Million USD | -1557.287% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -23.605% |
| ResMed Inc. | 697.31 Million USD | -681.715% |
| Henry Schein, Inc. | 1.93 Billion USD | -181.997% |
| Teladoc Health, Inc. | 1.58 Billion USD | -244.667% |
| Universal Health Services, Inc. | 4.71 Billion USD | -15.582% |
| Veeva Systems Inc. | 46.44 Million USD | -11637.473% |
| Baxter International Inc. | 11.06 Billion USD | 50.732% |
| Becton, Dickinson and Company | 14.73 Billion USD | 63.014% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 6739.464% |
| Danaher Corporation | 17.66 Billion USD | 69.135% |
| Stryker Corporation | 10.9 Billion USD | 49.995% |
| Medtronic plc | 23.87 Billion USD | 77.17% |